The histoplasmosis treatment market is estimated to be valued at USD 2.48 Bn in 2025 and is expected to reach USD 4.59 Bn by 2032. It is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2032. https://timessquarereporter.com/news/histoplasmosis-treatment-market-to-surge-with-antifungal-nanotechnology